-+ 0.00%
-+ 0.00%
-+ 0.00%

Vaxcyte Q1 EPS $(2.30) Misses $(1.82) Estimate

Benzinga·05/06/2026 20:35:40
Listen to the news
Vaxcyte (NASDAQ:PCVX) reported quarterly losses of $(2.30) per share which missed the analyst consensus estimate of $(1.82) by 26.37 percent. This is a 121.15 percent decrease over losses of $(1.04) per share from the same period last year.